rituximab
Jump to navigation
Jump to search
English[edit]
Alternative forms[edit]
Etymology[edit]
From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).
Pronunciation[edit]
- (General American) IPA(key): /ɹɪˈtʌk.sɪˌmæb/
Noun[edit]
rituximab (usually uncountable, plural rituximabs)
- (pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
References[edit]
- “rituximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.
Spanish[edit]
Pronunciation[edit]
Noun[edit]
rituximab f (plural rituximabs)
Categories:
- English terms interfixed with -tu-
- English terms suffixed with -ximab
- English 4-syllable words
- English terms with IPA pronunciation
- English lemmas
- English nouns
- English uncountable nouns
- English countable nouns
- en:Pharmaceutical drugs
- Spanish 4-syllable words
- Spanish terms with IPA pronunciation
- Rhymes:Spanish/ab
- Rhymes:Spanish/ab/4 syllables
- Spanish lemmas
- Spanish nouns
- Spanish countable nouns
- Spanish feminine nouns
- es:Organic compounds